HABIT: Health After Birth Intervention Trial

Sponsor
Queen Margaret University (Other)
Overall Status
Recruiting
CT.gov ID
NCT05137691
Collaborator
NHS Lothian (Other)
30
1
2
3
9.9

Study Details

Study Description

Brief Summary

This trial is to assess the feasibility of a larger, definitive RCT and determine the clinical effectiveness of an NHS 1:1 programme versus a modified programme with a low carbohydrate dietary intervention (as per Feinman and colleagues classification) with telehealth, physical activity and enhanced behaviour change on specified health outcomes amongst post-partum women living with obesity

Condition or Disease Intervention/Treatment Phase
  • Other: Adapted NHS weight management 1:1 programme
  • Other: NHS 1:1 weight management programme
N/A

Detailed Description

For individuals living with obesity, the post-partum period is currently the initial, optimal timeframe for weight management. Many women reconceive during the post-partum phase, increasing the risk of between-pregnancy bodyweight retention and even gain. Consequentially, many re-enter subsequent pregnancies with a higher BMI often associated with unfavourable obstetric outcome and further cyclical perpetuation.

Health behaviour change is an important facet within weight management interventions and delivery may be enhanced by digital technologies, for example, telehealth. Short messaging service (SMS) may be used to enhance communication between patients and practitioner and is relatively inexpensive to use.

Low carbohydrate diets continue to gain traction however research is arguably confounded by the lack of a universally agreed definition and classification. Feinman and colleagues (2015) propose intermediary categories. The experimental arm of this trial will be encouraged to adopt a non-ketogenic LCD as per Feinman.

Study Design

Study Type:
Interventional
Anticipated Enrollment :
30 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Intervention Model Description:
Feasibility Randomised Controlled TrialFeasibility Randomised Controlled Trial
Masking:
None (Open Label)
Primary Purpose:
Health Services Research
Official Title:
A Feasibility RCT Investigating the Effect of a Kilocalorie Controlled, Low Carbohydrate Dietary Intervention, Behavioural Modification and Telehealth vs a Standard 1:1 NHS Weight Management Programme in Post-partum Women Living With Obesity
Anticipated Study Start Date :
May 1, 2022
Anticipated Primary Completion Date :
Aug 1, 2022
Anticipated Study Completion Date :
Aug 1, 2022

Arms and Interventions

Arm Intervention/Treatment
Experimental: Experimental

Adapted NHS weight management 1:1 programme. Low carbohydrate dietary focus, enhanced behaviour change via telehealth, daily step target supported by pedometers

Other: Adapted NHS weight management 1:1 programme
Adapted NHS 1:1 weight management programme with a low carbohydrate dietary focus, incorporating enhanced behaviour change via telehealth, step count and pedometer

Active Comparator: Active comparator NHS 1:1 weight management programme

12 week NHS 1:1 weight management programme

Other: NHS 1:1 weight management programme
NHS 1:1 weight management programme

Outcome Measures

Primary Outcome Measures

  1. Change in Bodyweight (Kilograms) [Proposed 0,3,6,8 months]

    Bodyweight measured by the CI or self-reported

Secondary Outcome Measures

  1. Change in Body composition (Fat mass/fat free mass) [Proposed 0,3,6,8 months]

    Medical grade

  2. Change in Waist circumference (Centimetres) [Proposed 0,3,6,8 months]

    SECA Ergonomic measuring tape

  3. Change in systolic and diastolic Blood pressure [Proposed 0,3,6,8 months]

    Standard technique

  4. Change in Physical activity levels [Proposed 0,3,6,8 months]

    Level of physical activity (minutes) and step count from pedometer data

  5. Change in emotional eating using the Weight loss Readiness Test II [0,3,6,8 months]

    Incidence of emotional eating (if present) determined by change score. Increased score is less favourable

  6. Change in hunger and eating cues using the Weight loss Readiness Test II [0,3,6,8 months]

    Hunger and eating cues determined by change score. Increased score is less favourable

  7. Change in psychological distress (if present) using the Clinical Outcomes in Routine Evaluation-10 screening tool [Baseline, post-intervention at 3 months]

    Measured using the Clinical Outcomes in Routine Evaluation-10 tool using change scores. An increased score is less favourable

  8. Change in Quality of life [Proposed 0,3,6,8 months]

    Measured using the World Health Organisation Quality of life (BREF) tool. A lower score is less favourable

  9. Food frequency questionnaire [Baseline]

    Standard validated tool

  10. Diet quality [Proposed 0,3,6,8 months]

    Diet quality measured using a 3 day unweighed food diary

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years and Older
Sexes Eligible for Study:
Female
Accepts Healthy Volunteers:
Yes
Inclusion Criteria:
  • Adult aged 18 or above

  • Ready and motivated to make lifestyle changes

  • Have a Body Mass Index of ≥30 kg/m2 (at initial booking appointment)

Additional study specific criteria

  • English speaking and ability to read English language

  • Capacity to consent to participating in the study

  • Are non-diabetic or those with Type 2 diabetes which is diet controlled

  • Deemed medically fit by GP/medical professional to participate via email

  • Have recently given birth (within 1 year)

  • Are not receiving weight management support elsewhere e.g. NHS, Scottish slimmers, weight watchers

  • Have access to a mobile phone and weighing scales

Exclusion Criteria:
  • Have uncontrolled hypothyroidism

  • Have unstable psychosis or severe and unstable personality disorder

  • Are pregnant

  • Have dementia

  • Have moderate to severe learning disability or learning difficulty which impairs the ability to adhere to the programme (identified by medical history and confirmed with GP)

  • Current alcohol or substance misuse (6 month period of abstinence)

  • Active purging

  • Bulimia Nervosa

  • Binge Eating Disorder

Additional study specific criteria

  • Known cancers

  • Type 1 Diabetes or Type 2 Diabetes on any Diabetic medication (including Insulin)

  • Have a pacemaker

  • Renal impairment

  • Taking Orlistat or any other weight loss medication or had previous bariatric surgery

Contacts and Locations

Locations

Site City State Country Postal Code
1 Astley Ainslie Hospital Edinburgh United Kingdom EH9 2HL

Sponsors and Collaborators

  • Queen Margaret University
  • NHS Lothian

Investigators

  • Principal Investigator: Ashleigh Graham, Queen Margaret University

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Ashleigh Graham, Senior Practitioner in clinical research and Principal investigator, Queen Margaret University
ClinicalTrials.gov Identifier:
NCT05137691
Other Study ID Numbers:
  • 10052021
First Posted:
Nov 30, 2021
Last Update Posted:
Apr 27, 2022
Last Verified:
Apr 1, 2022
Individual Participant Data (IPD) Sharing Statement:
No
Plan to Share IPD:
No
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Keywords provided by Ashleigh Graham, Senior Practitioner in clinical research and Principal investigator, Queen Margaret University
Additional relevant MeSH terms:

Study Results

No Results Posted as of Apr 27, 2022